CCL5 and Insulin resistance: On the other hand, via GPR75, RANTES/CCL5 stimulates insulin secretion from β-cell lines [239] and mouse and human pancreatic islets in vitro, and improves glucose tolerance in lean mice and a mouse model of hyperglycaemia and insulin resistance without changing insulin sensitivity [237].